Brief: Xvivo Q4 EBIT SEK -16.1 Million
Jan 25 (Reuters) - Xvivo Q4 EPS SEK 2.17. * Q4 adjusted EBIT SEK 800 thousand * Q4 net income SEK 68.5 million * Q4 sales SEK 155.7 million vs. IBES estimate SEK 173.5 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength